Literature DB >> 26372390

Do HIV prevalence trends in antenatal clinic surveillance represent trends in the general population in the antiretroviral therapy era? The case of Manicaland, East Zimbabwe.

Simon Gregson1, Kanika Dharmayat, Monique Pereboom, Albert Takaruza, Owen Mugurungi, Nadine Schur, Constance A Nyamukapa.   

Abstract

OBJECTIVE: National estimates of HIV trends in generalized epidemics rely on HIV prevalence data from antenatal clinic (ANC) surveillance. We investigate whether HIV prevalence trends in ANC data reflect trends in men and women in the general population during the scale-up of antiretroviral therapy (ART) in Manicaland, Zimbabwe.
METHODS: Trends in HIV prevalence in local ANC attendees and adults aged 15-49 years in towns, agricultural estates, and villages were compared using five rounds of parallel ANC (N = 1200) and general-population surveys (N = 10 000) and multivariable log-linear regression. Changes in the age pattern of HIV prevalence and the age distribution of ANC attendees were compared with those in the general population. Age-specific pregnancy prevalence rates were compared by HIV infection and ART status.
RESULTS: Cumulatively, from 1998-2000 to 2009-2011, HIV prevalence fell by 60.0% (95% confidence interval, 51.1-67.3%) in ANC surveillance data and by 34.3% (30.8-37.7%) in the general population. Most of the difference arose following the introduction of ART (2006-2011). The estates and villages reflected this overall pattern but HIV prevalence in the towns was lower at local ANCs than in the general population, largely because of attendance by pregnant women from outlying (lower prevalence) areas. The ageing of people living with HIV in the general population (52.4% aged >35 years, 2009-2011) was under-represented in the ANC data (12.6%) because of lower fertility in older and HIV-infected women.
CONCLUSION: After the introduction of ART in Manicaland, HIV prevalence declined more steeply in ANC surveillance data than in the general population. Models used for HIV estimates must reflect this change in bias.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26372390      PMCID: PMC4880038          DOI: 10.1097/QAD.0000000000000754

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

1.  HIV and aging--preparing for the challenges ahead.

Authors:  Edward J Mills; Till Bärnighausen; Joel Negin
Journal:  N Engl J Med       Date:  2012-04-05       Impact factor: 91.245

2.  Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda.

Authors:  Marissa Maier; Irene Andia; Nneka Emenyonu; David Guzman; Angela Kaida; Larry Pepper; Robert Hogg; David R Bangsberg
Journal:  AIDS Behav       Date:  2008-04-04

3.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

4.  Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study.

Authors:  Landon Myer; Rosalind J Carter; Monica Katyal; Patricia Toro; Wafaa M El-Sadr; Elaine J Abrams
Journal:  PLoS Med       Date:  2010-02-09       Impact factor: 11.069

5.  The impact of HIV status and perceived status on fertility desires in rural Malawi.

Authors:  Sara E Yeatman
Journal:  AIDS Behav       Date:  2009-03-20

6.  Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.

Authors:  Sarah-Jane Anderson; Peter Cherutich; Nduku Kilonzo; Ide Cremin; Daniela Fecht; Davies Kimanga; Malayah Harper; Ruth Laibon Masha; Prince Bahati Ngongo; William Maina; Mark Dybul; Timothy B Hallett
Journal:  Lancet       Date:  2014-07-19       Impact factor: 79.321

Review 7.  A surprising prevention success: why did the HIV epidemic decline in Zimbabwe?

Authors:  Daniel T Halperin; Owen Mugurungi; Timothy B Hallett; Backson Muchini; Bruce Campbell; Tapuwa Magure; Clemens Benedikt; Simon Gregson
Journal:  PLoS Med       Date:  2011-02-08       Impact factor: 11.069

Review 8.  Updates to the spectrum model to estimate key HIV indicators for adults and children.

Authors:  John Stover; Kirill Andreev; Emma Slaymaker; Chaitra Gopalappa; Keith Sabin; Claudia Velasquez; Jessica Nakiyingi-Miiro; Amelia Crampin; Tom Lutalo; Kobus Herbst; Simon Gregson; Mark Urassa
Journal:  AIDS       Date:  2014-11       Impact factor: 4.177

9.  Comparison of HIV prevalence estimates from antenatal care surveillance and population-based surveys in sub-Saharan Africa.

Authors:  L S Montana; V Mishra; R Hong
Journal:  Sex Transm Infect       Date:  2008-08       Impact factor: 3.519

10.  Assessing and adjusting for differences between HIV prevalence estimates derived from national population-based surveys and antenatal care surveillance, with applications for Spectrum 2013.

Authors:  Kimberly Marsh; Mary Mahy; Joshua A Salomon; Daniel R Hogan
Journal:  AIDS       Date:  2014-11       Impact factor: 4.177

View more
  8 in total

Review 1.  Targeting Pregnant Women for Malaria Surveillance.

Authors:  Alfredo Mayor; Clara Menéndez; Patrick G T Walker
Journal:  Trends Parasitol       Date:  2019-08-05

2.  Effect of HIV Infection and Antiretroviral Treatment on Pregnancy Rates in the Western Cape Province of South Africa.

Authors:  Leigh F Johnson; Themba Mutemaringa; Alexa Heekes; Andrew Boulle
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

3.  Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe?

Authors:  Katherine C Wilson; Mutsa Mhangara; Janet Dzangare; Jeffrey W Eaton; Timothy B Hallett; Owen Mugurungi; Simon Gregson
Journal:  AIDS       Date:  2017-04       Impact factor: 4.177

4.  Using ante-natal clinic prevalence data to monitor temporal changes in malaria incidence in a humanitarian setting in the Democratic Republic of Congo.

Authors:  Joel Hellewell; Patrick Walker; Azra Ghani; Bhargavi Rao; Thomas S Churcher
Journal:  Malar J       Date:  2018-08-29       Impact factor: 2.979

5.  Difference in HIV prevalence by testing venue: results from population level survey in Uganda.

Authors:  Joseph Ouma; Caroline Jeffery; Joseph J Valadez; Rhoda K Wanyenze; Jim Todd; Jonathan Levin
Journal:  AIDS Care       Date:  2020-03-04

6.  Documenting and explaining the HIV decline in east Zimbabwe: the Manicaland General Population Cohort.

Authors:  Simon Gregson; Owen Mugurungi; Jeffrey Eaton; Albert Takaruza; Rebecca Rhead; Rufurwokuda Maswera; Junior Mutsvangwa; Justin Mayini; Morten Skovdal; Robin Schaefer; Timothy Hallett; Lorraine Sherr; Shungu Munyati; Peter Mason; Catherine Campbell; Geoffrey P Garnett; Constance Anesu Nyamukapa
Journal:  BMJ Open       Date:  2017-10-06       Impact factor: 2.692

7.  Combining national survey with facility-based HIV testing data to obtain more accurate estimate of HIV prevalence in districts in Uganda.

Authors:  Joseph Ouma; Caroline Jeffery; Joseph J Valadez; Rhoda K Wanyenze; Jim Todd; Jonathan Levin
Journal:  BMC Public Health       Date:  2020-03-23       Impact factor: 3.295

8.  Providing a conceptual framework for HIV prevention cascades and assessing feasibility of empirical measurement with data from east Zimbabwe: a case study.

Authors:  Geoffrey P Garnett; Timothy B Hallett; Albert Takaruza; James Hargreaves; Rebecca Rhead; Mitchel Warren; Constance Nyamukapa; Simon Gregson
Journal:  Lancet HIV       Date:  2016-07       Impact factor: 16.070

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.